JPMorgan (JPM) (JW-A) (LMT) (MJN) (MRX) Price Targets Changed

JPMorgan Chase & Co. (NYSE: JPM), John Wiley Sons (NASDAQ: JW-A), Lockheed Martin Co. (NYSE: LMT), Mead Johnson Nutrition (NYSE: MJN) and Medicis Pharmaceutic (NYSE: MRX) had price targets on them adjusted by analysts.

JPMorgan Chase & Co. (JPM) had its price target lowered by Goldman Sachs (NYSE:GS) to $43.00. They have a “Buy” rating on the company.

John Wiley Sons (JW-A) had its price target raised by JPMorgan Chase & Co. to $54.00.

Lockheed Martin Co. (LMT) had its price target lowered by HSBC (NYSE:HBC) from $85.00 to $82.00. They have a “Neutral” rating on the company.

Mead Johnson Nutrition (MJN) had its price target raised by Goldman Sachs (NYSE:GS) to $80.00. They have a “Neutral” rating on the company.

Medicis Pharmaceutic (MRX) had its price target raised by Morgan Stanley (NYSE:MS) to $38.00.